+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Primary biliary cirrhosis: Fenofibrate plus UDCA promising for incomplete responders to UDCA



Primary biliary cirrhosis: Fenofibrate plus UDCA promising for incomplete responders to UDCA



Nature Reviews. Gastroenterology and Hepatology 8(2): 63




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055174548

Download citation: RISBibTeXText

PMID: 21381242

DOI: 10.1038/nrgastro.2010.225


Related references

Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary Pharmacology and Therapeutics 43(2): 283-293, 2016

The efficacy of spark gap biliary extracorporeal shockwave lithotripsy esbl followed by ursodiol udca is decreased by gallstone calcification and may be increased by pre treatment with udca but gallstone disappearance is significantly more rapid with esbl plus udca than with udca alone. Hepatology 12(4 Part 2): 1023, 1990

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis. Drug Design Development and Therapy 9: 2757-2766, 2015

Biochemical, histological parameters and response to UDCA treatment in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Journal of Hepatology 34(Suppl. 1): 216, 2001

Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA. Revista Espanola de Enfermedades Digestivas 110(9): 557-563, 2018

A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon. Anticancer Research 29(12): 4971-4979, 2009

Unconjugated UDCA biliary mass in chronic cholestasis Effect of UDCA treatment. Journal of Hepatology 18(Suppl. 1): S120, 1993

Effect of udca administration on biliary lipid secretion and cholic acid metabolism in primary biliary cirrhosis. Gastroenterology 96(5 Part 2): A628, 1989

Different response to ursodeoxycholic acid udca in primary biliary cirrhosis pbc. Journal of Hepatology 16(Suppl. 1): S68, 1992

Comparative Research of Efficacy of Monotherapy with Udca and the Combination of Udca Gimekromonom C in Patients with Biliary Sludge2 Stages. Eksperimental'naia i Klinicheskaia Gastroenterologiia 10): 94-98, 2016

Predictive factors in primary biliary cirrhosis pbc under ursodeoxycholic udca therapy. Hepatology 14(4 Part 2): 195A, 1991

Rituximab for primary biliary cirrhosis (PBC) refractory to ursodeoxycholic acid (UDCA). 2007

Long-term UDCA therapy in the patients with primary biliary cirrhosis. Journal of Hepatology 32(Suppl. 2): 157, 2000

Bilirubin and albumin relationships in primary biliary cirrhosis Effect of UDCA. Journal of Hepatology 34(Suppl. 1): 210, 2001

Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. Journal of Lipid Research 42(3): 437-441, 2001